In recent years, Acinetobacter species have emerged as clinically impo
rtant pathogens. Though these organisms are widely prevalent in nature
, most human infections are hospital-acquired. Acinetobacter baumannii
is the predominant species. Nosocomial Acinetobacter baumannii infect
ions such as respiratory tract infections, urinary tract infections, m
eningitis following neurosurgical procedures, and bacteremia mainly af
fect patients with severe underlying disease in the ICU and often, in
the setting of a nosocomial outbreak. The occurrence of multiresistant
strains often limits therapeutic options. A substantial part of Acine
tobacter baumannii bacteremia cases represent catheter-related infecti
ons that usually carry a favorable prognosis. Acinetobacter species ot
her than Acinetobacter baumannii are less frequently reported as a cau
se of infection in humans. Bacteremia due to these organisms is mostly
sporadic and almost exclusively related to intravascular devices. The
underlying diseases are often less severe than those of patients affe
cted by Acinetobacter baumannii infections. The clinical course is usu
ally benign and the infection responds readily to catheter removal irr
espective of the appropriateness of antimicrobial therapy.